Product Description
The Point-of-Care or Rapid Diagnostics market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Point-of-Care or Rapid Diagnostics market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Point-of-Care or Rapid Diagnostics Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Point-of-Care or Rapid Diagnostics market are:
ARKRAY
Ascensia
Nova Biomedical
Ortho Clinical Diagnostics
Roche
BioMerieux
Trividia Health
OraSure Technologies
Johnson & Johnson
Abaxis (Zoetis)
Siemens Healthcare
A. Menarini Diagnostics
Accriva
Danaher
Abbott
Bio-Rad Laboratories
Most important types of Point-of-Care or Rapid Diagnostics products covered in this report are:
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Others
Most widely used downstream fields of Point-of-Care or Rapid Diagnostics market covered in this report are:
Clinics
Hospitals
Laboratory
Others
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.
